Test our high-quality Human Alpha-Syn Fibrils in your cell-based Alpha-Synuclein assay
We’re sending 20 μg samples to selected participants for free. Developed, manufactured and released with a comprehensive Certificate of Analysis. Fill out the form to be considered.
Our proprietary high potency fibrils are designed to deliver robust and reproducible aggregation results.
*Limited availability. The Evaluation Program ends December 31, 2026.
Want to test how these fibrils can improve the reliability of your assay — for free?
Bioneer has over 100 publications in CNS research, including collaborations with Lundbeck and Johnson & Johnson.
Read more about us and how you can validate your drug candidate’s efficacy in our alpha-synuclein aggregation assay.
Read about our Parkinson´s Disease Models here.
